Behavioral analyses of transgenic mice harboring bipolar disorder candidate genes, IMPA1 and IMPA2

被引:10
|
作者
Ohnishi, Tetsuo [1 ]
Watanabe, Akiko [1 ]
Ohba, Hisako [1 ]
Iwayama, Yoshimi [1 ]
Maekawa, Motoko [1 ]
Yoshikawa, Takeo [1 ,2 ]
机构
[1] RIKEN, Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan
[2] Japan Sci & Technol Agcy, CREST, Tokyo, Japan
关键词
Bipolar disorder; Lithium; Inositol; Mood stabilizer; Inositol depletion hypothesis; Transgenic mouse; Myo-inositol monophosphatase; TAIL SUSPENSION TEST; MYOINOSITOL MONOPHOSPHATASE; INOSITOL MONOPHOSPHATASE; FEBRILE SEIZURES; MOOD DISORDER; MOUSE-BRAIN; LITHIUM; EXPRESSION; SUSCEPTIBILITY; TELENCEPHALIN;
D O I
10.1016/j.neures.2010.02.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The inositol depletion hypothesis proposes the inhibition of IMPase (myo-inositol monophosphatase) by lithium, a mood stabilizer, as a mechanism of lithium's efficacy. This hypothesis predicts that the upregulation of this biochemical pathway may underlie the pathophysiology of bipolar disorder. In favor of this idea, IMPA2 encoding IMPase is a candidate susceptibility gene for bipolar disorder and that the risk-conferring single nucleotide polymorphisms enhance the promoter activity of IMPA2. However, it is yet unknown whether such upregulation has a biological role in bipolar disorder. To address this issue, we generated transgenic mice for the two IMPase genes (IMPA1 and IMPA2). The expression levels of the transgene were robust in IMPA2 Tg lines, but moderate in IMPA1 Tg lines, when compared to those of endogenous proteins. The transgenic mice behaved normally under durg-naive conditions, and did not exhibit signs for manic change when an antidepressant amitriptyline was administrated. Interestingly, the male transgenic mice for IMPA2 exhibited a lithium-resistant phenotype in the forced swim test. The current study, as a whole, did not support a substantial role of the upregulation of IMPase in bipolar disorder, although the lithium-insensitivity trait seen in IMPA2 transgenic mice might represent some aspect relevant to the inositol depletion hypothesis. (C) 2010 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
引用
收藏
页码:86 / 94
页数:9
相关论文
共 31 条
  • [21] A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription
    Ohnishi, Tetsuo
    Yamada, Kazuo
    Ohba, Hisako
    Iwayama, Yoshimi
    Toyota, Tomoko
    Hattori, Eiji
    Inada, Toshiya
    Kunugi, Hiroshi
    Tatsumi, Masahiko
    Ozaki, Norio
    Iwata, Nakao
    Sakamoto, Kaoru
    Iijima, Yoshimi
    Iwata, Yasuhide
    Tsuchiya, Kenji J.
    Sugihara, Genichi
    Nanko, Shinichiro
    Osumi, Noriko
    Detera-Wadleigh, Sevilla D.
    Kato, Tadafumi
    Yoshikawa, Takeo
    NEUROPSYCHOPHARMACOLOGY, 2007, 32 (08) : 1727 - 1737
  • [22] A Promoter Haplotype of the Inositol Monophosphatase 2 Gene (IMPA2) at 18p11.2 Confers a Possible Risk for Bipolar Disorder by Enhancing Transcription
    Tetsuo Ohnishi
    Kazuo Yamada
    Hisako Ohba
    Yoshimi Iwayama
    Tomoko Toyota
    Eiji Hattori
    Toshiya Inada
    Hiroshi Kunugi
    Masahiko Tatsumi
    Norio Ozaki
    Nakao Iwata
    Kaoru Sakamoto
    Yoshimi Iijima
    Yasuhide Iwata
    Kenji J Tsuchiya
    Genichi Sugihara
    Shinichiro Nanko
    Noriko Osumi
    Sevilla D Detera-Wadleigh
    Tadafumi Kato
    Takeo Yoshikawa
    Neuropsychopharmacology, 2007, 32 : 1727 - 1737
  • [23] Integrative analyses to identify candidate causal genes for bipolar 2 disorder
    Bakir, Ebru
    Can, Gunes
    Oktay, Yavuz
    BIPOLAR DISORDERS, 2024, 26 : 127 - 127
  • [24] Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response Association With IMPA2, INPP1, and GSK3B Genes
    Mitjans, Marina
    Arias, Barbara
    Jimenez, Esther
    Goikolea, Jose M.
    Saiz, Pilar A.
    Paz Garcia-Portilla, M.
    Buron, Patricia
    Bobes, Julio
    Vieta, Eduard
    Benabarre, Antoni
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (05) : 600 - 604
  • [25] A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients
    G Sjøholt
    A K Gulbrandsen
    R Løvlie
    JØ Berle
    A Molven
    V M Steen
    Molecular Psychiatry, 2000, 5 : 172 - 180
  • [26] A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2:: genomic structure and polymorphism screening in manic-depressive patients
    Sjoholt, G
    Gulbrandsen, AK
    Lovlie, R
    Berle, JO
    Molven, A
    Steen, VM
    MOLECULAR PSYCHIATRY, 2000, 5 (02) : 172 - 180
  • [27] Human myo-inositol monophosphatase 2 rescues the nematode thermotaxis mutant ttx-7 more efficiently than IMPA1: functional and evolutionary considerations of the two mammalian myo-inositol monophosphatase genes
    Ohnishi, Tetsuo
    Tanizawa, Yoshinori
    Watanabe, Akiko
    Nakamura, Takemichi
    Ohba, Hisako
    Hirata, Haruna
    Kaneda, Chizu
    Iwayama, Yoshimi
    Arimoto, Takafumi
    Watanabe, Kazutada
    Mori, Ikue
    Yoshikawa, Takeo
    JOURNAL OF NEUROCHEMISTRY, 2013, 124 (05) : 685 - 694
  • [28] Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes
    Souery, D
    Lipp, O
    Mahieu, B
    Mendelbaum, K
    DeMartelaer, V
    Van Broeckhoven, C
    Mendlewicz, J
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1996, 67 (06): : 551 - 555
  • [29] NRG1, PIP4K2A, and HTR2C as Potential Candidate Biomarker Genes for Several Clinical Subphenotypes of Depression and Bipolar Disorder
    Levchenko, Anastasia
    Vyalova, Natalia M.
    Nurgaliev, Timur
    Pozhidaev, Ivan V.
    Simutkin, German G.
    Bokhan, Nikolay A.
    Ivanova, Svetlana A.
    FRONTIERS IN GENETICS, 2020, 11
  • [30] Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5
    Kirov, G
    Jones, I
    McCandless, F
    Craddock, N
    Owen, MJ
    MOLECULAR PSYCHIATRY, 1999, 4 (06) : 558 - 565